CN111018950B - 一种腺苷七肽及其制备菌株 - Google Patents
一种腺苷七肽及其制备菌株 Download PDFInfo
- Publication number
- CN111018950B CN111018950B CN201911127892.0A CN201911127892A CN111018950B CN 111018950 B CN111018950 B CN 111018950B CN 201911127892 A CN201911127892 A CN 201911127892A CN 111018950 B CN111018950 B CN 111018950B
- Authority
- CN
- China
- Prior art keywords
- heptapeptide
- adenosine
- strain
- fermentation
- lactobacillus johnsonii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 title claims abstract description 128
- 239000002126 C01EB10 - Adenosine Substances 0.000 title claims abstract description 64
- 229960005305 adenosine Drugs 0.000 title claims abstract description 64
- 238000000034 method Methods 0.000 claims abstract description 18
- 241001468157 Lactobacillus johnsonii Species 0.000 claims abstract description 16
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 238000004321 preservation Methods 0.000 claims abstract description 5
- 238000000855 fermentation Methods 0.000 claims description 42
- 230000004151 fermentation Effects 0.000 claims description 42
- 239000001963 growth medium Substances 0.000 claims description 11
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- 239000001888 Peptone Substances 0.000 claims description 3
- 108010080698 Peptones Proteins 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 229940041514 candida albicans extract Drugs 0.000 claims description 3
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 3
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 3
- 229940099596 manganese sulfate Drugs 0.000 claims description 3
- 235000007079 manganese sulphate Nutrition 0.000 claims description 3
- 239000011702 manganese sulphate Substances 0.000 claims description 3
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 3
- 244000005700 microbiome Species 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 235000019319 peptone Nutrition 0.000 claims description 3
- 239000012138 yeast extract Substances 0.000 claims description 3
- 239000002609 medium Substances 0.000 claims description 2
- 108090000631 Trypsin Proteins 0.000 abstract description 13
- 102000004142 Trypsin Human genes 0.000 abstract description 13
- 239000012588 trypsin Substances 0.000 abstract description 13
- 108090000284 Pepsin A Proteins 0.000 abstract description 12
- 102000057297 Pepsin A Human genes 0.000 abstract description 12
- 229940111202 pepsin Drugs 0.000 abstract description 12
- 108091005804 Peptidases Proteins 0.000 abstract description 10
- 239000004365 Protease Substances 0.000 abstract description 10
- 238000013537 high throughput screening Methods 0.000 abstract description 10
- 108090000317 Chymotrypsin Proteins 0.000 abstract description 9
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 9
- 229960002376 chymotrypsin Drugs 0.000 abstract description 9
- 230000028327 secretion Effects 0.000 abstract description 4
- 238000009629 microbiological culture Methods 0.000 abstract description 3
- 239000002537 cosmetic Substances 0.000 abstract description 2
- 230000036541 health Effects 0.000 abstract description 2
- 244000144972 livestock Species 0.000 abstract description 2
- 229960001322 trypsin Drugs 0.000 abstract description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 230000003385 bacteriostatic effect Effects 0.000 description 16
- 230000005764 inhibitory process Effects 0.000 description 14
- 239000007788 liquid Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 241000588724 Escherichia coli Species 0.000 description 11
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 11
- 230000000968 intestinal effect Effects 0.000 description 11
- 210000004051 gastric juice Anatomy 0.000 description 10
- 102000035195 Peptidases Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 238000012216 screening Methods 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 238000012258 culturing Methods 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000000306 component Substances 0.000 description 4
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 101100344625 Shewanella oneidensis (strain MR-1) sirA gene Proteins 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000000415 inactivating effect Effects 0.000 description 3
- 101150009914 mccA gene Proteins 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- WTLKTXIHIHFSGU-UHFFFAOYSA-N 2-nitrosoguanidine Chemical compound NC(N)=NN=O WTLKTXIHIHFSGU-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 229950006790 adenosine phosphate Drugs 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 230000000529 probiotic effect Effects 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 244000153158 Ammi visnaga Species 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 102000044503 Antimicrobial Peptides Human genes 0.000 description 1
- 108700042778 Antimicrobial Peptides Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108010062877 Bacteriocins Proteins 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- 241000587240 Cynanchum Species 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241001406038 Lactobacillus johnsonii NCC 533 Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- OETYBDQHOHLNBH-GNXGYILWSA-N c7 peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](N)CC=1C=CC=CC=1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CN)[C@@H](C)O)C1=CC=C(O)C=C1 OETYBDQHOHLNBH-GNXGYILWSA-N 0.000 description 1
- KLOIYEQEVSIOOO-UHFFFAOYSA-N carbocromen Chemical compound CC1=C(CCN(CC)CC)C(=O)OC2=CC(OCC(=O)OCC)=CC=C21 KLOIYEQEVSIOOO-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000010812 external standard method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 108010032877 galanin (1-13)-spantide amide Proteins 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 1
- 239000001393 triammonium citrate Substances 0.000 description 1
- 235000011046 triammonium citrate Nutrition 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/02—Separating microorganisms from their culture media
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911127892.0A CN111018950B (zh) | 2019-11-18 | 2019-11-18 | 一种腺苷七肽及其制备菌株 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911127892.0A CN111018950B (zh) | 2019-11-18 | 2019-11-18 | 一种腺苷七肽及其制备菌株 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111018950A CN111018950A (zh) | 2020-04-17 |
CN111018950B true CN111018950B (zh) | 2022-01-04 |
Family
ID=70200437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911127892.0A Active CN111018950B (zh) | 2019-11-18 | 2019-11-18 | 一种腺苷七肽及其制备菌株 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111018950B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111809247A (zh) * | 2020-07-23 | 2020-10-23 | 宁波酶赛生物工程有限公司 | 一种L-天冬氨酸α-脱羧酶基因突变库的高通量筛选方法 |
CN111778193B (zh) * | 2020-07-23 | 2022-12-16 | 安杰利(重庆)生物科技有限公司 | 一种约氏乳杆菌及其制备的腺苷七肽、制备方法 |
CN113072627B (zh) * | 2020-11-02 | 2022-07-05 | 重庆市畜牧科学院 | MccJ25突变体及其制备方法和应用 |
CN113150069B (zh) * | 2021-02-24 | 2022-07-22 | 安杰利(重庆)生物科技有限公司 | 一种透明质酸酶抑制剂及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109400685A (zh) * | 2018-10-30 | 2019-03-01 | 中国农业大学 | 一种耐受胰蛋白酶的抗菌肽 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7655775B2 (en) * | 1997-09-05 | 2010-02-02 | Canbiocin, Inc. | Expression vectors for treating bacterial infections |
US20080233086A1 (en) * | 1997-09-05 | 2008-09-25 | Canbiocin Inc. | Expression Vectors for Treating Bacterial Infections |
US10022423B2 (en) * | 2012-06-15 | 2018-07-17 | Washington State University | Microcin and uses thereof |
-
2019
- 2019-11-18 CN CN201911127892.0A patent/CN111018950B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109400685A (zh) * | 2018-10-30 | 2019-03-01 | 中国农业大学 | 一种耐受胰蛋白酶的抗菌肽 |
Non-Patent Citations (4)
Title |
---|
Antioxidant peptides purified and identified from the oil palm (Elaeis guineensis Jacq.) kernel protein hydrolysate;Sui Kiat Chang等;《Journal of Functional Foods》;20150206;第14卷;全文 * |
Enzymatic Synthesis of Bioinformatically Predicted Microcin C-Like Compounds Encoded by Diverse Bacteria;Olga Bantysh;《mBio.》;20140506;第5卷(第3期);全文 * |
Microcin C7七肽及其类似物对大肠杆菌生长的影响;冉仁森;《中国优秀硕士学位论文全文数据库(电子期刊)》;20180115(第1期);全文 * |
Sequence analysis and functional characterization of the promoter of the Picea glauca Cinnamyl Alcohol Dehydrogenase gene in transgenic white spruce plants;Frank Bedon等;《Plant Cell Rep》;20090314;第28卷;全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN111018950A (zh) | 2020-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111018950B (zh) | 一种腺苷七肽及其制备菌株 | |
CN109423465B (zh) | 一种控制黄曲霉毒素b1的复合生物制剂及其应用 | |
CN113430173B (zh) | 一株宽裂解谱、耐高温沙门氏菌噬菌体及其应用 | |
CN112940970B (zh) | 一种肠道益生菌及其在治疗肿瘤和替代抗生素中的应用 | |
CN106636050A (zh) | 来源于耐甲氧西林金黄色葡萄球菌噬菌体的宽谱内溶素及其应用 | |
CN109777758A (zh) | 一种具有广谱抑菌活性的地衣芽胞杆菌hyt-9及其菌剂制备方法和应用 | |
CN105779346B (zh) | 一种产细菌素的屎肠球菌及其应用 | |
CN113142214B (zh) | 甲基营养型芽孢杆菌wswGH-10的抗菌蛋白的应用及分离纯化方法 | |
CN111778178B (zh) | 海洋灰平链霉菌hn60在抗细菌方面的应用 | |
Chin et al. | Bioprocess optimization for biomass production of probiotics yeast Saccharomyces boulardii in semi-industrial scale | |
CN103882029B (zh) | 一种非洲帝王蝎抗菌肽基因、抗菌肽Pi_4、其结构同源抗菌肽、制备方法和应用 | |
KR100427600B1 (ko) | 바실러스 아밀로리쿼파시엔스 및 이를 포함하는 사료 첨가제 | |
CN113061550B (zh) | 一株乳杆菌新菌株z6及其在食品中的应用 | |
CN102492639A (zh) | 利用rna聚合酶突变提高环脂肽类抗生素产量的突变体及制法和应用 | |
CN115637240A (zh) | 一种贝莱斯芽孢杆菌及其应用 | |
CN112391312B (zh) | 一种新种链霉菌及其在防治植物卵菌病害中的应用 | |
CN110241052B (zh) | 一株高产叶酸植物乳杆菌gslp-7及其应用 | |
Ali et al. | Biosynthesis and optimization of bacitracin by mutant Bacillus licheniformis using submerged fermentation | |
Evangelista-Martínez et al. | Antibacterial activity of Streptomyces sp. Y15 against pathogenic bacteria and evaluation of culture media for antibiotic production | |
Rajan et al. | Screening, Production and Characterization of extracellular glutaminase free L-Asparaginase producing endo-symbiontic bacteria from the gut of Mugil cephalus (Mullet fish) | |
CN108004181B (zh) | 一株甲基营养型芽孢杆菌及其培养物和应用 | |
CN114621884A (zh) | 一株枯草芽孢杆菌及其在水质净化中的应用 | |
Khandelwal et al. | Studies on Bacteriocin producing abilities of indigenously isolated lactic acid bacteria strains | |
CN111040975B (zh) | 一株产酶、喜盐芽孢杆菌及其在咸水水产养殖防治病原菌中的应用 | |
CN114836330B (zh) | 一种蜡样芽孢杆菌的抑制物制备方法及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231211 Address after: 402460 No. 57, Lingfang Avenue, Banqiao Industrial Park, Changzhou street, Rongchang District, Chongqing Patentee after: Anjeli (Chongqing) Biotechnology Co.,Ltd. Address before: 402460 No.51 Changlong Avenue, Changzhou street, Rongchang District, Chongqing Patentee before: CHONGQING ACADEMY OF ANIMAL SCIENCES |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240126 Address after: Room B-215, "Chongmu Silicon Valley Xingchuang Tiandi", No. 178 Xiangyang Road, Changzhou Street, Rongchang District, Chongqing, 402460 Patentee after: Daozhiyuan (Chongqing) Biotechnology Co.,Ltd. Country or region after: China Address before: 402460 No. 57, Lingfang Avenue, Banqiao Industrial Park, Changzhou street, Rongchang District, Chongqing Patentee before: Anjeli (Chongqing) Biotechnology Co.,Ltd. Country or region before: China |